GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BlackRock Health Sciences Trust II (NYSE:BMEZ) » Definitions » Piotroski F-Score

BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Piotroski F-Score

: 6 (As of Today)
View and export this data going back to 1990. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

BlackRock Health Sciences Trust II has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for BlackRock Health Sciences Trust II's Piotroski F-Score or its related term are showing as below:

BMEZ' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 6

During the past 4 years, the highest Piotroski F-Score of BlackRock Health Sciences Trust II was 6. The lowest was 2. And the median was 4.


BlackRock Health Sciences Trust II Piotroski F-Score Historical Data

The historical data trend for BlackRock Health Sciences Trust II's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BlackRock Health Sciences Trust II Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 2.00 6.00

BlackRock Health Sciences Trust II Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only N/A - 2.00 - 6.00

Competitive Comparison

For the Asset Management subindustry, BlackRock Health Sciences Trust II's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BlackRock Health Sciences Trust II Piotroski F-Score Distribution

For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Trust II's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where BlackRock Health Sciences Trust II's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was $69.86 Mil.
Cash Flow from Operations was $224.79 Mil.
Revenue was $71.50 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (2085.822 + 1954.072) / 2 = $2019.947 Mil.
Total Assets at the begining of this year (Dec22) was $2,085.82 Mil.
Long-Term Debt & Capital Lease Obligation was $0.29 Mil.
Total Assets was $1,954.07 Mil.
Total Liabilities was $46.70 Mil.
Net Income was $-682.72 Mil.

Revenue was $-680.95 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (3018.271 + 2085.822) / 2 = $2552.0465 Mil.
Total Assets at the begining of last year (Dec21) was $3,018.27 Mil.
Long-Term Debt & Capital Lease Obligation was $0.10 Mil.
Total Assets was $2,085.82 Mil.
Total Liabilities was $29.40 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

BlackRock Health Sciences Trust II's current Net Income (TTM) was 69.86. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

BlackRock Health Sciences Trust II's current Cash Flow from Operations (TTM) was 224.79. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=69.859/2085.822
=0.03349231

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-682.718/3018.271
=-0.22619506

BlackRock Health Sciences Trust II's return on assets of this year was 0.03349231. BlackRock Health Sciences Trust II's return on assets of last year was -0.22619506. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

BlackRock Health Sciences Trust II's current Net Income (TTM) was 69.86. BlackRock Health Sciences Trust II's current Cash Flow from Operations (TTM) was 224.79. ==> 224.79 > 69.86 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.292/2019.947
=0.00014456

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=0.095/2552.0465
=3.723E-5

BlackRock Health Sciences Trust II's gearing of this year was 0.00014456. BlackRock Health Sciences Trust II's gearing of last year was 3.723E-5. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

* Note that for banks and insurance companies, there's no Total Current Assets and Total Current Liabilities reported. Thus, we use Total Assets and Total Liabilities to calculate current ratio for banks and insurance companies.

Current Ratio (This Year: Dec23)=Total Assets/Total Liabilities
=1954.072/46.701
=41.84218753

Current Ratio (Last Year: Dec22)=Total Assets/Total Liabilities
=2085.822/29.403
=70.93908785

BlackRock Health Sciences Trust II's current ratio of this year was 41.84218753. BlackRock Health Sciences Trust II's current ratio of last year was 70.93908785. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

BlackRock Health Sciences Trust II's number of shares in issue this year was 95.697. BlackRock Health Sciences Trust II's number of shares in issue last year was 114.358. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

* Note that for banks and insurance companies, there's no Gross Profit reported. Thus, we use net income instead of gross profit and calculate Net Margin for this score.

Net Margin (This Year: TTM)=Net Income/Revenue
=69.859/71.503
=0.97700796

Net Margin (Last Year: TTM)=Net Income/Revenue
=-682.718/-680.953
=1.00259196

BlackRock Health Sciences Trust II's net margin of this year was 0.97700796. BlackRock Health Sciences Trust II's net margin of last year was 1.00259196. ==> Last year's net margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=71.503/2085.822
=0.03428049

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=-680.953/3018.271
=-0.22561029

BlackRock Health Sciences Trust II's asset turnover of this year was 0.03428049. BlackRock Health Sciences Trust II's asset turnover of last year was -0.22561029. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+1+0+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

BlackRock Health Sciences Trust II has an F-score of 6 indicating the company's financial situation is typical for a stable company.

BlackRock Health Sciences Trust II  (NYSE:BMEZ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


BlackRock Health Sciences Trust II Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of BlackRock Health Sciences Trust II's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


BlackRock Health Sciences Trust II (BlackRock Health Sciences Trust II) Business Description

Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
BlackRock Health Sciences Trust II is a closed-end management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Frank Fabozzi director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert Glenn Hubbard director 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212